✦ LIBER ✦

356: Phase-II Study of Infliximab for the Prophylaxis of Acute Graft-Versus-Host Disease (GVHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (AHSCT)

✍ Scribed by M. Hamadani; G. Phillips; P. Elder; B. Jansak; W. Blum; S. Penza; T.S. Lin; S.S. Farag; S.M. Devine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Features of Acute Cutaneous Gra

✍ Bach, Daniel; Damstetter, Elizabeth; West, Dennis; Mehta, Jayesh; Cotliar, Jonat 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 133 KB

Addition of Infliximab to Standard Acute

✍ Mehdi Hamadani; Craig C. Hofmeister; Buffy Jansak; Gary Phillips; Patrick Elder; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 254 KB

109Single-agent tacrolimus for prophylax

✍ J.E. Schwartz; D.M. BuchBarker; D.L. Griffin; Magalhaes-Silverman M. de; A.D. Do 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 278 KB

The history and future of T-cell depleti

✍ Ho, V. T. 📂 Article 📅 2001 🏛 American Society of Hematology 🌐 English ⚖ 273 KB

Plasma level of lipopolysaccharide-bindi

✍ Ye, Haige; Lv, Meng; Zhao, Xiaosu; Zhao, Xiangyu; Huang, Xiaojun 📂 Article 📅 2012 🏛 Carden Jennings Publishing 🌐 English ⚖ 484 KB

Low-dose methotrexate for the treatment

✍ Huang, X-J; Jiang, Q; Chen, H; Xu, L; Liu, D; Chen, Y; Han, W; Zhang, Y; Liu, K; 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 114 KB